← Oncology Approval Tracker

FDA DECISION ·

Rylaze

asparaginase erwinia chrysanthemi (recombinant)-rywn · Jazz Pharmaceuticals

FDA approvalNew dosing regimenAcute lymphoblastic leukemia and lymphoblastic lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adds an intramuscular Monday/Wednesday/Friday schedule in multiagent treatment of ALL or lymphoblastic lymphoma from age one month after hypersensitivity to E. coli-derived asparaginase.

LAMPGEN ANALYSIS

Why it matters

The alternate schedule changes administration timing while serving the established substitution population.

What research teams should watch

Plan the Monday and Wednesday doses and the larger Friday dose around the longer weekend interval.

PRIMARY RECORDS

Sources